A Phase 1b Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study Assessing the PK, Pharmacodynamics, Safety, and Tolerability of SB414 in Subjects With Psoriasis
Phase of Trial: Phase I
Latest Information Update: 20 Aug 2018
At a glance
- Drugs Nitric oxide (Primary)
- Indications Psoriasis
- Focus Pharmacokinetics
- Sponsors Novan Inc
- 20 Aug 2018 Results published in the Media Release
- 15 May 2018 According to a Novan Inc media release, PK and PD data analysis from this trial is ongoing.
- 26 Mar 2018 Status changed from active, no longer recruiting to completed.